2022 ICD-10-CM Code D70.1
Agranulocytosis secondary to cancer chemotherapy
Valid for Submission
| ICD-10: | D70.1 |
| Short Description: | Agranulocytosis secondary to cancer chemotherapy |
| Long Description: | Agranulocytosis secondary to cancer chemotherapy |
Code Classification
D70.1 is a billable diagnosis code used to specify a medical diagnosis of agranulocytosis secondary to cancer chemotherapy. The code D70.1 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D70.1 might also be used to specify conditions or terms like neutropenia due to and following chemotherapy.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D70.1:
Code Also
Code AlsoA "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- underlying neoplasm
Use Additional Code
Use Additional CodeThe “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
- code for adverse effect, if applicable, to identify drug T45.1X5
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D70.1 are found in the index:
- - Agranulocytosis (chronic) (cyclical) (genetic) (infantile) (periodic) (pernicious) - See Also: Neutropenia; - D70.9
- - cytoreductive cancer chemotherapy sequela - D70.1
- - drug-induced - D70.2
- - due to cytoreductive cancer chemotherapy - D70.1
- - secondary - D70.4
- - drug-induced - D70.2
- - due to cytoreductive cancer chemotherapy - D70.1
- - drug-induced - D70.2
- - Leukopenia - D72.819
- - chemotherapy (cancer) induced - D70.1
- - drug induced NEC - D70.2
- - due to cytoreductive cancer chemotherapy - D70.1
- - Neutropenia, neutropenic (chronic) (genetic) (idiopathic) (immune) (infantile) (malignant) (pernicious) (splenic) - D70.9
- - cytoreductive cancer chemotherapy sequela - D70.1
- - drug-induced - D70.2
- - due to cytoreductive cancer chemotherapy - D70.1
- - secondary (cyclic) (periodic) (splenic) - D70.4
- - drug-induced - D70.2
- - due to cytoreductive cancer chemotherapy - D70.1
- - drug-induced - D70.2
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Neutropenia due to and following chemotherapy
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D70.1 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 808 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC | 16 | 2.1779 |
| 809 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC | 16 | 1.2217 |
| 810 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC | 16 | 0.9607 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D70.1 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D70.1 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 288.03 - Drug induced neutropenia (Approximate Flag)
Information for Patients
Blood Disorders
Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.
Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet.
Types of blood disorders include
- Platelet disorders, excessive clotting, and bleeding problems, which affect how your blood clots
- Anemia, which happens when your blood does not carry enough oxygen to the rest of your body
- Cancers of the blood, such as leukemia and myeloma
- Eosinophilic disorders, which are problems with one type of white blood cell.
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)